[
  {
    "ts": null,
    "headline": "Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology",
    "summary": "Bio-Techne (NASDAQ: TECH), a global leader in life science tools and reagents, today announced the launch of an expanded menu of human and mouse RNAscope™ in situ hybridization probes to advance spatial biology research and the development of next-generation therapeutics and diagnostics. Designed to deliver spatial precision with industry-leading sensitivity and specificity, the Advanced Cell Diagnostics (ACD) branded RNAscope probe portfolio now includes over 70,000 unique probes across over 45",
    "url": "https://finnhub.io/api/news?id=e9211f330e3edd394582341b200e686c4a93f8b1a03b9e1f9ab3ee6e7a418af2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740052800,
      "headline": "Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology",
      "id": 133193887,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "Bio-Techne (NASDAQ: TECH), a global leader in life science tools and reagents, today announced the launch of an expanded menu of human and mouse RNAscope™ in situ hybridization probes to advance spatial biology research and the development of next-generation therapeutics and diagnostics. Designed to deliver spatial precision with industry-leading sensitivity and specificity, the Advanced Cell Diagnostics (ACD) branded RNAscope probe portfolio now includes over 70,000 unique probes across over 45",
      "url": "https://finnhub.io/api/news?id=e9211f330e3edd394582341b200e686c4a93f8b1a03b9e1f9ab3ee6e7a418af2"
    }
  },
  {
    "ts": null,
    "headline": "Aristotle Focus Growth Q4 2024 Commentary",
    "summary": "For Q4 2024, Aristotle Atlanticâs Focus Growth Composite posted a total return of 5.05% gross of fees, underperforming the 7.07% total return of the Russell 1000 Growth Index.",
    "url": "https://finnhub.io/api/news?id=7a7974d6724ca3dca59a1dcb0755777fe0e585d984660622df800c8771bf154c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740045600,
      "headline": "Aristotle Focus Growth Q4 2024 Commentary",
      "id": 132802605,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/165180102/image_165180102.jpg?io=getty-c-w1536",
      "related": "TECH",
      "source": "SeekingAlpha",
      "summary": "For Q4 2024, Aristotle Atlanticâs Focus Growth Composite posted a total return of 5.05% gross of fees, underperforming the 7.07% total return of the Russell 1000 Growth Index.",
      "url": "https://finnhub.io/api/news?id=7a7974d6724ca3dca59a1dcb0755777fe0e585d984660622df800c8771bf154c"
    }
  },
  {
    "ts": null,
    "headline": "Aristotle Large Cap Growth Q4 2024 Commentary",
    "summary": "For Q4 2024, Aristotle Atlanticâs Large Cap Growth Composite posted a total return of 6.29% gross of fees, underperforming the 7.07% return of the Russell 1000 Growth Index.",
    "url": "https://finnhub.io/api/news?id=0682376595e315b4aaa043fb1c8a03a5f04c7ca7eccb5d8e631030d9d5b6d8aa",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740045600,
      "headline": "Aristotle Large Cap Growth Q4 2024 Commentary",
      "id": 132802578,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2182036952/image_2182036952.jpg?io=getty-c-w1536",
      "related": "TECH",
      "source": "SeekingAlpha",
      "summary": "For Q4 2024, Aristotle Atlanticâs Large Cap Growth Composite posted a total return of 6.29% gross of fees, underperforming the 7.07% return of the Russell 1000 Growth Index.",
      "url": "https://finnhub.io/api/news?id=0682376595e315b4aaa043fb1c8a03a5f04c7ca7eccb5d8e631030d9d5b6d8aa"
    }
  }
]